We are live on ! Find out more
LMR Partners

LMR Partners Portfolio holdings

AUM $32.6B Turnover 45.82%
1-Year Est. Return 45.61%
 

LMR Partners is a British multi-strategy investment firm named after its three founders, Ben Levine, Andrew Manuel and Stefan Renold, whose surname initials spell LMR. All three had been traders at UBS and Goldman Sachs, and Paloma Partners provided seed money before the firm began trading in 2010. Manuel left in 2015 and launched Ixworth Capital, his own global macro hedge fund. The firm focuses on global macro and event-driven strategies, mixing computer-model trading with trades chosen by its portfolio managers.

This Fund
S&P 500
This Quarter Est. Return
+4.46%
1 Year Est. Return
+45.61%
3 Year Est. Return
+238.3%
5 Year Est. Return
+283.63%
10 Year Est. Return
+733.38%
AUM
$32.6B
AUM Growth
+$5.8B
Cap. Flow
-$2.24B
Cap. Flow %
-6.88%
Top 10 Hldgs %
23.21%
Holding
1,999
New
513
Increased
354
Reduced
302
Closed
403
Avg Time Held Equity + Options
0.7 years
Top 10 Avg Time Held Equity + Options
0.2 years
Top 20 Avg Time Held Equity + Options
0.4 years
Avg Time Held Equity only
0.7 years
Top 10 Avg Time Held Equity only
0.5 years
Top 20 Avg Time Held Equity only
0.6 years

Top Buys

Rank Stock Value
1
LNTH icon
Lantheus
LNTH
+$215M
2
NVS icon
Novartis
NVS
+$116M
3
LITE icon
Lumentum
LITE
+$91.8M
4
MDT icon
Medtronic
MDT
+$90.8M
5
SHOP icon
Shopify
SHOP
+$88.5M

Sector Composition

Rank Sector Weight
1 Miscellaneous 74.57%
2 Technology 7.25%
3 Healthcare 5.19%
4 Communication Services 3.16%
5 Financials 2.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
T icon
1126
AT&T
T
$148B
$745K ﹤0.01%
30,534
-25,885
-46% -$624K
2025 Q2
5 quarters
CTMX icon
1127
CytomX Therapeutics
CTMX
$410M
$743K ﹤0.01%
273,213
– –
2026 Q1
2 quarters
FAST icon
1128
Fastenal
FAST
$61.9B
$732K ﹤0.01%
14,772
+8,987
+155% +$440K
2026 Q2
1 quarter
WDC icon
1129
CALL
Western Digital
WDC
$108B
$727K ﹤0.01%
+1,600
New +$778K
2026 Q3
0 quarters
BLK icon
1130
Blackrock
BLK
$181B
$723K ﹤0.01%
683
-115
-14% -$126K
2026 Q1
2 quarters
ATIIW icon
1131
DELISTED
Archimedes Tech SPAC Partners II Co Warrant
ATIIW
$706K ﹤0.01%
613,701
– –
2025 Q2
5 quarters
NEM icon
1132
Newmont
NEM
$109B
$702K ﹤0.01%
6,089
+1,329
+28% +$149K
2026 Q2
1 quarter
CHYM icon
1133
Chime Financial
CHYM
$12.4B
$701K ﹤0.01%
+26,303
New +$729K
2026 Q3
0 quarters
BRBS icon
1134
Blue Ridge Bankshares
BRBS
$355M
$697K ﹤0.01%
+181,030
New +$678K
2026 Q3
0 quarters
DSGX icon
1135
Descartes Systems
DSGX
$7.79B
$696K ﹤0.01%
+8,602
New +$656K
2026 Q3
0 quarters
NVMI icon
1136
Nova
NVMI
$9.9B
$690K ﹤0.01%
+1,791
New +$714K
2026 Q3
0 quarters
ATTO
1137
Attovia Therapeutics
ATTO
$710M
$686K ﹤0.01%
+40,000
New +$842K
2026 Q3
0 quarters
EVRG icon
1138
Evergy
EVRG
$20.4B
$685K ﹤0.01%
8,727
+5,002
+134% +$415K
2026 Q2
1 quarter
LLY icon
1139
Eli Lilly
LLY
$1.23T
$683K ﹤0.01%
590
-2,800
-83% -$3.3M
2024 Q1
10 quarters
ALMR icon
1140
Alamar Biosciences
ALMR
$2.12B
$681K ﹤0.01%
20,000
-155,000
-89% -$4.57M
2026 Q2
1 quarter
VLTO icon
1141
Veralto
VLTO
$28.7B
$674K ﹤0.01%
7,145
-2,222
-24% -$212K
2026 Q2
1 quarter
APA icon
1142
APA
APA
$15.3B
$665K ﹤0.01%
+16,012
New +$636K
2026 Q3
0 quarters
WING icon
1143
Wingstop
WING
$4.21B
$661K ﹤0.01%
6,277
-2,523
-29% -$313K
2026 Q2
1 quarter
STT icon
1144
State Street
STT
$44.9B
$656K ﹤0.01%
3,755
+1,426
+61% +$264K
2026 Q2
1 quarter
INGR icon
1145
Ingredion
INGR
$5.6B
$653K ﹤0.01%
6,817
+4,104
+151% +$415K
2026 Q2
1 quarter
NTWOW icon
1146
Newbury Street II Acquisition Corp Warrant
NTWOW
$5.08M
$653K ﹤0.01%
725,000
– –
2025 Q1
6 quarters
DYNC icon
1147
DELISTED
Dynamix Corp
DYNC
$645K ﹤0.01%
59,199
– –
2025 Q1
6 quarters
GCTS.WS icon
1148
GCT Semiconductor Holding Warrants
GCTS.WS
$9.46M
$643K ﹤0.01%
1,994,271
+78,282
+4% +$26.7K
2024 Q4
7 quarters
CB icon
1149
Chubb
CB
$142B
$641K ﹤0.01%
1,972
+649
+49% +$224K
2026 Q2
1 quarter
BNY icon
1150
Bank of New York Mellon
BNY
$99.5B
$636K ﹤0.01%
4,400
-10,732
-71% -$1.69M
2026 Q2
1 quarter

Similar funds

LMR Partners's Q3 2026 Portfolio in Review

As of Q3 2026, LMR Partners held 1,999 positions worth $32.6B, up 22% from $26.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

LMR Partners withdrew a net $2.24B in Q3 2026, closing 403 positions and reducing 302 holdings. Its most notable exit was Chart Industries, an estimated $109M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 75% of assets, up from 71% a quarter earlier, followed by Technology and Healthcare.

Against the trend, LMR Partners opened a new position in Lantheus worth $210M.

  • LMR Partners's largest Q3 2026 buy was Lantheus: 2,108,000 shares worth $210M.
  • LMR Partners added most to Novartis in Q3 2026, an estimated $116M increase.
  • LMR Partners's biggest Q3 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $632M.
  • LMR Partners fully exited Chart Industries in Q3 2026, selling an estimated $109M.
  • LMR Partners's ten largest holdings make up 23% of its $32.6B portfolio in Q3 2026.
  • LMR Partners opened 513 new positions and closed 403 in Q3 2026.
  • LMR Partners's portfolio value rose 22% quarter-over-quarter to $32.6B.

Based on LMR Partners's 13F filing for Q3 2026, filed 16 Nov 2026.